Clinical evidence for synergy between immunotherapy and radiotherapy (SITAR).
SABR
checkpoint inhibitor
immunotherapy
radiotherapy
stereotactic
Journal
Journal of medical imaging and radiation oncology
ISSN: 1754-9485
Titre abrégé: J Med Imaging Radiat Oncol
Pays: Australia
ID NLM: 101469340
Informations de publication
Date de publication:
Sep 2022
Sep 2022
Historique:
received:
14
02
2022
accepted:
25
05
2022
pubmed:
15
6
2022
medline:
8
9
2022
entrez:
14
6
2022
Statut:
ppublish
Résumé
Previous preclinical and clinical trials have shown promising antitumour activity and toxicity profile when employing the 'Synergy between Immunotherapy and Radiotherapy' (SITAR) strategy. Approximately, one in seven radiation therapy studies currently recruiting is investigating SITAR. This article reviews the range of cancers known to respond to immunotherapy and publications analysing SITAR. It sets the background for work that needs to be done in future clinical trials. It also reviews the potential toxicities of immunotherapy and discusses areas where caution is required when combining treatments.
Identifiants
pubmed: 35699321
doi: 10.1111/1754-9485.13441
pmc: PMC9543060
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
881-895Informations de copyright
© 2022 The Authors. Journal of Medical Imaging and Radiation Oncology published by John Wiley & Sons Australia, Ltd on behalf of Royal Australian and New Zealand College of Radiologists.
Références
Eur Urol. 2022 Mar;81(3):253-262
pubmed: 34493414
Cancer Lett. 2015 Jan 1;356(1):82-90
pubmed: 24125863
JAMA Oncol. 2019 Sep 01;5(9):1276-1282
pubmed: 31294749
Intern Med. 2020 May 1;59(9):1199-1202
pubmed: 32051381
Thorac Cancer. 2019 Apr;10(4):992-1000
pubmed: 30888716
Lancet. 2021 Jan 30;397(10272):375-386
pubmed: 33485464
N Engl J Med. 2017 Nov 16;377(20):1919-1929
pubmed: 28885881
N Engl J Med. 2015 Nov 5;373(19):1803-13
pubmed: 26406148
Lancet Oncol. 2017 Jan;18(1):31-41
pubmed: 27932067
Nat Med. 2021 Feb;27(2):212-224
pubmed: 33574607
Semin Urol Oncol. 1996 Nov;14(4):216-22
pubmed: 8946620
Oncoimmunology. 2016 Aug 19;5(9):e1214788
pubmed: 27757312
Eur Urol. 2020 Dec;78(6):822-830
pubmed: 32811715
Eur J Cancer. 2016 Nov;68:156-162
pubmed: 27764686
Clin Transl Radiat Oncol. 2017 Dec 23;9:5-11
pubmed: 29594244
Cancer Discov. 2022 Jan;12(1):108-133
pubmed: 34479871
J Nucl Med. 2022 May;63(5):686-693
pubmed: 34385342
Lancet. 2016 May 7;387(10031):1909-20
pubmed: 26952546
J Clin Oncol. 2020 Jul 20;38(21):2427-2437
pubmed: 32479189
Eur J Cancer. 2021 Feb;144:232-241
pubmed: 33373868
J Clin Oncol. 2021 Jan 1;39(1):1-3
pubmed: 32986527
Clin Breast Cancer. 2021 Apr;21(2):143-152
pubmed: 33810972
Clin Transl Immunology. 2020 Sep 10;9(9):e1169
pubmed: 32994997
N Engl J Med. 2010 Aug 19;363(8):711-23
pubmed: 20525992
Front Oncol. 2020 Sep 29;10:570233
pubmed: 33117699
N Engl J Med. 2020 Dec 3;383(23):2207-2218
pubmed: 33264544
Nat Med. 2019 Jun;25(6):920-928
pubmed: 31086347
Eur Radiol Exp. 2020 Jan 3;4(1):2
pubmed: 31900689
Expert Rev Anticancer Ther. 2016;16(1):13-20
pubmed: 26588948
Cancer. 2020 Feb 15;126(4):850-860
pubmed: 31747077
Cancer Med. 2020 Nov;9(22):8355-8363
pubmed: 32886446
Radiat Res. 2013 May;179(5):584-9
pubmed: 23510275
J Immunother Cancer. 2021 May;9(5):
pubmed: 33986125
J Thorac Oncol. 2021 Feb;16(2):278-288
pubmed: 33188912
J Clin Oncol. 2021 Jan 1;39(1):30-37
pubmed: 32822275
N Engl J Med. 2015 Jan 22;372(4):320-30
pubmed: 25399552
Radiat Res. 2012 Dec;178(6):505-23
pubmed: 23106210
Lancet Oncol. 2020 Jan;21(1):44-59
pubmed: 31786121
N Engl J Med. 2019 Mar 21;380(12):1116-1127
pubmed: 30779529
JAMA Oncol. 2021 Jul 01;7(7):1051-1059
pubmed: 33885725
J Radiat Res. 2021 Jul 10;62(4):669-675
pubmed: 34121123
JAMA Oncol. 2021 Aug 01;7(8):1225-1230
pubmed: 34196693
N Engl J Med. 2016 Nov 10;375(19):1823-1833
pubmed: 27718847
J Clin Oncol. 2021 Mar 1;39(7):723-733
pubmed: 33449799
J Immunother Cancer. 2021 Jul;9(7):
pubmed: 34301810
J Thorac Oncol. 2019 Oct;14(10):1794-1806
pubmed: 31228626
Clin Cancer Res. 2020 May 15;26(10):2318-2326
pubmed: 31996388
Nat Med. 2018 Dec;24(12):1845-1851
pubmed: 30397353
Cancer Res. 2018 Feb 15;78(4):1031-1043
pubmed: 29222400
Int J Radiat Oncol Biol Phys. 2019 Jul 15;104(4):828-835
pubmed: 30951807
PLoS One. 2017 Feb 21;12(2):e0171559
pubmed: 28222111
Clin Cancer Res. 2021 Mar 1;27(5):1236-1241
pubmed: 33199494
Case Rep Oncol. 2018 Feb 15;11(1):114-118
pubmed: 29606949
Lancet Oncol. 2021 Apr;22(4):450-462
pubmed: 33794205
Clin Cancer Res. 2021 Jun 15;27(12):3351-3359
pubmed: 33504550
Clin Cancer Res. 2017 Mar 15;23(6):1388-1396
pubmed: 27649551
BMC Cancer. 2020 Sep 1;20(1):831
pubmed: 32873251
Eur Urol. 2022 Mar;81(3):274-282
pubmed: 34602312
Acta Derm Venereol. 2020 Mar 31;100(6):adv00100
pubmed: 32176308
Curr Oncol. 2020 Apr;27(Suppl 2):S87-S97
pubmed: 32368178
Nat Commun. 2017 Jun 09;8:15618
pubmed: 28598415
Eur Urol. 2022 Apr;81(4):364-372
pubmed: 34953600
Clin Cancer Res. 2009 Sep 1;15(17):5379-88
pubmed: 19706802
Front Oncol. 2021 Mar 25;11:648655
pubmed: 33842363
Int J Radiat Oncol Biol Phys. 2020 Sep 1;108(1):170-177
pubmed: 31756415
N Engl J Med. 2019 Oct 17;381(16):1535-1546
pubmed: 31562797
JAMA Oncol. 2020 Nov 01;6(11):e204564
pubmed: 33001135
Eur Urol Oncol. 2021 Oct;4(5):745-754
pubmed: 33243663
Clin Genitourin Cancer. 2020 Aug;18(4):e397-e401
pubmed: 31919032
Lancet Oncol. 2021 Aug;22(8):1093-1102
pubmed: 34237249
Neuro Oncol. 2019 Jan 1;21(1):139-141
pubmed: 30476174
Melanoma Res. 2017 Oct;27(5):485-491
pubmed: 28858075
Lancet Oncol. 2015 Jul;16(7):795-803
pubmed: 26095785
Neuro Oncol. 2021 Apr 12;23(4):677-686
pubmed: 33173935
Mol Cancer Ther. 2020 Dec;19(12):2409-2421
pubmed: 33087511
Cancer Biol Ther. 2017 Jan 2;18(1):36-42
pubmed: 27905824
Cancer Immunol Immunother. 2005 Apr;54(4):307-14
pubmed: 15599732
Int J Radiat Oncol Biol Phys. 2018 Aug 1;101(5):1168-1171
pubmed: 30012528
Lancet Oncol. 2014 Jun;15(7):700-12
pubmed: 24831977
Lancet Oncol. 2017 Jul;18(7):895-903
pubmed: 28551359
N Engl J Med. 2017 Mar 16;376(11):1015-1026
pubmed: 28212060
J Immunother Cancer. 2018 Dec 22;6(1):153
pubmed: 30577851
N Engl J Med. 2018 Dec 6;379(23):2220-2229
pubmed: 30280641
Cancer Treat Res Commun. 2019;19:100116
pubmed: 30682445
N Engl J Med. 2010 Jul 29;363(5):411-22
pubmed: 20818862
N Engl J Med. 2015 Jun 25;372(26):2521-32
pubmed: 25891173
Clin Cancer Res. 2021 Oct 1;27(19):5188-5194
pubmed: 34140404
J Natl Cancer Inst. 1979 Nov;63(5):1229-35
pubmed: 291749
BMC Cancer. 2020 Oct 13;20(1):991
pubmed: 33050910
Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):1128-35
pubmed: 21093169
Contemp Clin Trials Commun. 2021 Jan 06;21:100703
pubmed: 33490707
Tumori. 2022 Jun;108(3):250-257
pubmed: 33818208
J Clin Oncol. 2020 Sep 1;38(25):2830-2838
pubmed: 32484754
CA Cancer J Clin. 2020 Mar;70(2):86-104
pubmed: 31944278
J Thorac Oncol. 2022 Jan;17(1):130-140
pubmed: 34500113
Lung Cancer. 2019 Jul;133:83-87
pubmed: 31200833
Future Oncol. 2020 Jun;16(18):1235-1243
pubmed: 32490686